Evidence map›Paper›PMID 32224164›Full record

ArticleDiabetes research and clinical practice2020

COVID-19 and diabetes: Can DPP4 inhibition play a role?

Gianluca Iacobellis

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetes research and clinical practice, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04341935 (Effects of DPP4 Inhibition on COVID-19 Patients With Type 2 Diabetes), which is not on this map. Cited by 175 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
175citing papers in PubMed, 11 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04341935 phase4withdrawnnot on this mapstarted 2021, after this paper: background citation

Effects of DPP4 Inhibition on COVID-19 Patients With Type 2 Diabetes

TypeinterventionalSponsorUniversity of MiamiRan2021 to 2021Enrolled0ConditionsCoronavirus Infection, Type 2 DiabetesArmsLinagliptin, Insulin regimen
3 · Its place in the literature

Who cites it

175 citing papers in PubMed, 11 syntheses or guidelines pooled it.

  1. SARS-CoV-2 cell entry beyond the ACE2 receptor.Molecular biology reports · 2022
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Diabetes and COVID-19: A systematic review on the current evidences.Diabetes research and clinical practice · 2020
    Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Trial
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Effects of Glycemic Variability in Critically Ill Patients with Coronavirus Disease 2019: A Retrospective Observational Study.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2024
    Article

115 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Gianluca IacobellisDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Miami, FL, USA. Electronic address: giacobellis@med.miami.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BetacoronavirusCoronavirus InfectionsCOVID-19Diabetes ComplicationsDiabetes MellitusDipeptidyl Peptidase 4Dipeptidyl-Peptidase IV InhibitorsHumansHypoglycemic AgentsPandemicsPneumonia, ViralSARS-CoV-2Dipeptidyl Peptidase 4Dipeptidyl-Peptidase IV InhibitorsDPP4 protein, humanHypoglycemic Agents

Identifiers

PMID32224164
PMCPMC7271223

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.